These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10460615)

  • 41. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complete remission in acute myeloid leukaemia after treatment with recombinant human granulocyte colony-stimulating factor and high dose intravenous methylprednisolone.
    Sugawara T; Sato A; Shishido T; Okuda M; Kameoka J; Meguro K; Endo K; Yoshinaga K
    Br J Haematol; 1991 Apr; 77(4):561-2. PubMed ID: 1709041
    [No Abstract]   [Full Text] [Related]  

  • 43. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
    Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S
    Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased numbers of bone marrow blasts in acute myeloid leukaemia patients treated with G-CSF after chemotherapy.
    Kaddar A; Edinger M; Wirth K; Schaefer HE; Lübbert M; Lindemann A
    Br J Haematol; 1997 Aug; 98(2):492-3. PubMed ID: 9266958
    [No Abstract]   [Full Text] [Related]  

  • 45. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
    Ehlers S; Herbst C; Zimmermann M; Scharn N; Germeshausen M; von Neuhoff N; Zwaan CM; Reinhardt K; Hollink IH; Klusmann JH; Lehrnbecher T; Roettgers S; Stary J; Dworzak M; Welte K; Creutzig U; Reinhardt D
    J Clin Oncol; 2010 May; 28(15):2591-7. PubMed ID: 20406937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A complex karyotype masked a cryptic variant t(8;21)(q22;q22) in a child with acute myeloid leukemia.
    De Figueiredo AF; Liehr T; Bhatt S; Binato R; De Souza MT; De Matos RR; Salles Tde J; Jordy FC; Ribeiro RC; Abdelhay E; Silva ML
    Leuk Lymphoma; 2011 Aug; 52(8):1593-6. PubMed ID: 21657952
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
    Estey E; Thall P; Andreeff M; Beran M; Kantarjian H; O'Brien S; Escudier S; Robertson LE; Koller C; Kornblau S
    J Clin Oncol; 1994 Apr; 12(4):671-8. PubMed ID: 7512125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].
    Wakazono Y; Kataoka A; Fusaoka T; Tunamoto K
    Rinsho Ketsueki; 1998 Jul; 39(7):499-505. PubMed ID: 9750457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
    Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
    Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymphoblastic leukemia [corrected].
    Wang HY; Tirado CA
    Hum Pathol; 2010 Feb; 41(2):286-92. PubMed ID: 19896694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia.
    Sultana TA; Harada H; Ito K; Tanaka H; Kyo T; Kimura A
    Br J Haematol; 2003 Apr; 121(1):63-75. PubMed ID: 12670333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia.
    Braess J; Jahns-Streubel G; Schoch C; Haase D; Haferlach T; Fiegl M; Voss S; Kern W; Schleyer E; Hiddemann W
    Br J Haematol; 2001 Jun; 113(4):975-82. PubMed ID: 11442492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. G-CSF-induced remission in two cases of acute myeloid leukemia.
    Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
    Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of granulocyte- and granulocyte-macrophage-colony-stimulating factors in the treatment of acute myeloid leukaemia.
    Johnson PR; Yin JA
    Br J Haematol; 1997 Apr; 97(1):1-8. PubMed ID: 9136935
    [No Abstract]   [Full Text] [Related]  

  • 56. Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature.
    Xu X; Su M; Levy NB; Mohtashamian A; Monaghan S; Kaur P; Zaremba C; Garcia R; Broome HE; Dell'Aquila ML; Wang HY
    Leuk Lymphoma; 2014 Nov; 55(11):2532-7. PubMed ID: 24397594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML?
    Potenza L; Luppi M; Riva G; Ottaviani E; Zucchini P; Morselli M; Volzone F; Forghieri F; Martinelli G; Torelli G
    Leuk Res; 2007 Feb; 31(2):269-71. PubMed ID: 16759701
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
    Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P
    Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CytCD79a expression in acute leukemia with t(8;21): biphenotypic or myeloid leukemia?
    He G; Wu D; Sun A; Xue Y; Jin Z; Qiu H; Miao M; Tang X; Fu Z; Chen Z
    Cancer Genet Cytogenet; 2007 Apr; 174(1):76-7. PubMed ID: 17350472
    [No Abstract]   [Full Text] [Related]  

  • 60. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
    Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.